Table 1.
Patient, Disease, & Transplant Characteristics
| Inpatient N=135 (%) |
Outpatient N=95 (%) |
P Value | |
|---|---|---|---|
| Age at Transplant | |||
| Median (range) | 59 (21–76) | 58 (20–76) | 0.418 |
| Sex | 0.683 | ||
| Male | 86 (63.7) | 63 (66.3) | |
| Female | 49 (36.3) | 32 (33.7) | |
| KPS | <0.001 | ||
| </=80 | 36 (26.7) | 6 (6.3) | |
| 90 | 72 (53.3) | 49 (51.6) | |
| 100 | 27 (20.0) | 40 (42.1) | |
| HCT-CI | 0.060 | ||
| 0–2 | 64 (47.4) | 57 (60.0) | |
| 3+ | 71 (52.6) | 38 (40.0) | |
| Malignancy | 0.859 | ||
| Myeloma | 88 (65.2) | 63 (66.3) | |
| Lymphoma/Other* | 47 (34.8) | 32 (33.7) | |
| Disease Status | 0.241 | ||
| Chemo-Resistant | 5 (3.7) | 7 (7.4) | |
| Chemo-Sensitive | 130 (96.3) | 88 (92.6) | |
| #CD34(x106)/kg median (range) | 4.6 (1.9–16.5) | 4.4 (1.9–12.9) | 0.581 |
| Conditioning Regimen | |||
| BEAM | 45 (33.3) | 32 (33.6) | 1.000 |
| Mel 140 | 17 (12.6) | 1 (1.1) | 0.0008 |
| Mel 200 | 71 (52.6) | 57 (60.0) | 0.283 |
| Other** | 2 (1.5) | 5 (5.3) | 0.128 |
| Length of Stay | |||
| Median LOS, days (range) | 19 (13–36) | 0 (0–44) | <0.001 |
| Mean LOS, days (95% CI) | 19.2 (18.6–19.8) | 5.4 (3.9–6.9) | <0.0001 |
*
POEMS, Waldenstrom’s Macroglobulinemia, Plasma Cell Leukemia
**
Inpatient: Mel 120, Mel 160
**
Outpatient: Mel 160, Mel180, Mel Unknown (n=2), Mel 200/Vel